Cisplatin‐mediated down‐regulation of miR‐145 contributes to up‐regulation of PD‐L1 via the c‐Myc transcription factor in cisplatin‐resistant ovarian carcinoma cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cisplatin‐mediated down‐regulation of miR‐145 contributes to up‐regulation of PD‐L1 via the c‐Myc transcription factor in cisplatin‐resistant ovarian carcinoma cells
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-12-10
DOI
10.1111/cei.13406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Progress in Gene Therapy for Ovarian Cancer
- (2018) Ángela Áyen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis
- (2018) Matteo Caforio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- New Dancing Couple: PD-L1 and MicroRNA
- (2017) A. Grenda et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Down regulation of miR-143 promotes radiation – Induced thymic lymphoma by targeting B7H1
- (2017) Hainan Zhao et al. TOXICOLOGY LETTERS
- Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells
- (2017) Rachel M. Gibbons Johnson et al. Frontiers in Immunology
- Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1)
- (2016) Shingo Inaguma et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application
- (2016) Masaki Mandai et al. International Journal of Clinical Oncology
- Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Robert J. Morgan et al. Journal of the National Comprehensive Cancer Network
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Ovarian cancer: beyond resistance
- (2015) David Holmes NATURE
- Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
- (2015) Shabnam Shalapour et al. NATURE
- Overview of MicroRNA Biology
- (2015) Ashley Mohr et al. SEMINARS IN LIVER DISEASE
- Immune Checkpoint Protein Inhibition for Cancer: Preclinical Justification for CTLA-4 and PD-1 Blockade and New Combinations
- (2015) Kathryn Baksh et al. SEMINARS IN ONCOLOGY
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Paclitaxel Induced B7-H1 Expression in Cancer Cells via the MAPK Pathway
- (2014) Wenrong Gong et al. JOURNAL OF CHEMOTHERAPY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1
- (2013) Huijuan Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer
- (2013) C.-C. Yu et al. CANCER RESEARCH
- Comparative microRNA Profiling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing
- (2013) Martin Hart et al. MOLECULAR CANCER RESEARCH
- Screening of differentially expressed microRNA in ulcerative colitis related colorectal cancer
- (2013) Yong-Gang Tan et al. Asian Pacific Journal of Tropical Medicine
- Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways
- (2012) Shunsuke Noguchi et al. CANCER LETTERS
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
- (2011) Jelena Radojicic et al. CELL CYCLE
- MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1
- (2011) William CS Cho et al. RNA Biology
- miRNA profiling along tumour progression in ovarian carcinoma
- (2010) Olga Vaksman et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
- (2009) M. J. Szczepanski et al. CLINICAL CANCER RESEARCH
- MicroRNA Regulation of Oncolytic Herpes Simplex Virus-1 for Selective Killing of Prostate Cancer Cells
- (2009) C. Y. F. Lee et al. CLINICAL CANCER RESEARCH
- Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation
- (2009) William C.S. Cho et al. EUROPEAN JOURNAL OF CANCER
- p53 represses c-Myc through induction of the tumor suppressor miR-145
- (2009) M. Sachdeva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer
- (2008) Mark J. Dobrzanski et al. CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started